Lucio Luzzatto1, Pier Paolo Pandolfi. 1. From the Istituto Toscano Tumori and University of Firenze, Florence, Italy (L.L.); and the Cancer Research Institute and Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston (P.P.P.).
Authors: Marco Tafani; Luigi Sansone; Federica Limana; Tania Arcangeli; Elena De Santis; Milena Polese; Massimo Fini; Matteo A Russo Journal: Oxid Med Cell Longev Date: 2015-12-20 Impact factor: 6.543